Texas Southern University is requesting support for the Center for Biomedical and Health Research Excellence (CBHRE) formerly known as the Institute for Biomedical and Health Disparities Research. The purpose of the CBHRE is to support the conduct of research on two diseases, cancer and cardiovascular, which are leading causes of death in Houston, the state of Texas and the nation. The RCMI program is being reinvented and reinvigorated. The goals of the program are to: 1) upgrade research infrastructure to enhance the university's biomedical research capacity and help promote a research rich environment;2) enable investigators to become more successful in obtaining competitive extramural support for the conduct of biomedical research, particularly on diseases that disproportionately impact minority populations;and 3) foster vibrant environments conducive to professional development in biomedical sciences. Based on these goals, at the end of five years of RCMI support the CHBRE proposes multiple outcomes including substantial increases in publications citing NIH support;more proposal submissions;more grants awarded;increased number of investigators receiving """"""""mainstream"""""""" extramural grant support;and increased number of professional development activities. The CBHRE will have an evaluation component that will be responsible for monitoring the progress of the CBHRE at regular intervals and making recommendations for improvement. The CBHRE will institute a Pilot Program project using a rigorous set of criteria and investigators supported by this program will undergo professional development activities that will help them gain independence within two years of completion of the CBHRE program. The CBHRE and agreed on college and university resources will be leveraged to form new and strengthen collaborations. The CBHRE will be organized into the following activities and/or cores: Administrative Core, Collaborations and Partnerships, Pilot Project Program, Professional Development, Assessment and Evaluation, Environmental Toxicology Research Core, Molecular Biology Research Core and Pharmacology Research Core. Each activity and/or core is designed to support the purpose, goals and objectives of the CBHRE. The core research laboratories will be organized in a manner that will allow investigators access to the state-of-the-art facilities, instrumentatio and service oriented scientific expertise. Multiple investigators will come together to conduct research on cancer and cardiovascular diseases based on discovering common biological, biochemical, genomic, lipidomic, and/or proteomic malfunctions to help understand the mechanistic and clinical relevance of the disease processes.

Public Health Relevance

The focus of the research supported by the CBHRE will be cancer and cardiovascular diseases that disproportionately affect minority populations and lead to burdensome morbidity and mortality among this community. Collectively, cardiovascular disease (including stroke), cancer, and diabetes account for approximately two-thirds of all deaths in the U.S. and about $700 billion in direct and indirect economic costs each year. The CBHRE proposes to approach the study of these diseases by marshaling all of its former, current and future biomedical research resources to launch a three-pronged approach to discovering new mechanistic information about the underlying causes of these diseases and identifying prospective remedies.

National Institute of Health (NIH)
National Institute on Minority Health and Health Disparities (NIMHD)
Research Centers in Minority Institutions Award (G12)
Project #
Application #
Study Section
Special Emphasis Panel (ZMD1-RN (04))
Program Officer
Mcclure, Shelia A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Texas Southern University
Schools of Pharmacy
United States
Zip Code
Gupta, Ritu; Xie, Huan (2018) Nanoparticles in Daily Life: Applications, Toxicity and Regulations. J Environ Pathol Toxicol Oncol 37:209-230
Ekpenyong, Oscar; Cooper, Candace; Ma, Jing et al. (2018) A simple, sensitive and reliable LC-MS/MS method for the determination of 7-bromo-5-chloroquinolin-8-ol (CLBQ14), a potent and selective inhibitor of methionine aminopeptidases: Application to pharmacokinetic studies. J Chromatogr B Analyt Technol Biomed Life Sci 1097-1098:35-43
Jordan, Brian C; Kumar, Bhavna; Thilagavathi, Ramasamy et al. (2018) Synthesis, evaluation of cytotoxic properties of promising curcumin analogues and investigation of possible molecular mechanisms. Chem Biol Drug Des 91:332-337
Skelton, Felicia; Grigoryan, Larissa; Holmes, Sally Ann et al. (2018) Routine Urine Testing at the Spinal Cord Injury Annual Evaluation Leads to Unnecessary Antibiotic Use: A Pilot Study and Future Directions. Arch Phys Med Rehabil 99:219-225
Chen, Yuan; Bian, Xiaomei; Aliru, Maureen et al. (2018) Hypoxia-targeted gold nanorods for cancer photothermal therapy. Oncotarget 9:26556-26571
Selvam, Chelliah; Jordan, Brian C; Prakash, Sandhya et al. (2017) Pterocarpan scaffold: A natural lead molecule with diverse pharmacological properties. Eur J Med Chem 128:219-236
Selvam, Chelliah; Mutisya, Daniel; Prakash, Sandhya et al. (2017) Therapeutic potential of chemically modified siRNA: Recent trends. Chem Biol Drug Des 90:665-678
Robinson, Jenaye; Okoro, Esther; Ezuedu, Chinoso et al. (2017) Effects of Hydrogen Sulfide-Releasing Compounds on Aqueous Humor Outflow Facility in Porcine Ocular Anterior Segments, Ex Vivo. J Ocul Pharmacol Ther 33:91-97
White, Lyndsey; Ma, Jing; Liang, Su et al. (2017) LC-MS/MS determination of d-mannose in human serum as a potential cancer biomarker. J Pharm Biomed Anal 137:54-59
Joshi, Jugal Bharat; Patel, Divya; Morton, Derrick J et al. (2017) Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52. Mol Oncol 11:337-357

Showing the most recent 10 out of 33 publications